Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ:SCNI)

2.260 -0.010 (-0.44%)
Streaming Delayed Price Updated: 3:33 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,694
Open 2.200
Bid (Size) 2.160 (2)
Ask (Size) 2.400 (1)
Prev. Close 2.270
Today's Range 2.167 - 2.310
52wk Range 1.900 - 8.920
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights Growth and SEPA Funding Ahead of BIO 2025 CEO Participation
Via Investor Brand Network
Which stocks are moving on Friday?
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill

Performance

YTD
-34.3%
-34.3%
1 Month
-19.9%
-19.9%
3 Month
-34.4%
-34.4%
6 Month
-33.3%
-33.3%
1 Year
-47.8%
-47.8%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Discover the top movers in Friday's pre-market session.
Via Chartmill
Cases of Parvovirus B19 Spike in the US
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Italian Clearance for Option to Acquire Biotech Firm Pincell
Via Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q1 Revenue Growth Driven by CDMO Contracts, Net Loss Narrows
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports $4.8 Million Net Gain in 2024, Driven by Loan-to-Equity Conversion
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Host Webinar on PC111 Antibody for Rare Skin Disorders
Via Investor Brand Network
InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell
Via Investor Brand Network
InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Present at BIO-Europe Spring 2025
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters $10 Million Standby Equity Purchase Agreement
Via Investor Brand Network
Layoffs, Upheaval at CDC Trigger Fears on Handling Disease Outbreaks
Via Investor Brand Network
Topics Government Workforce
Exposures Layoff Political
Biomaterial Modification Could Yield Better Cancer Therapies, Study Finds
Via Investor Brand Network
New Trump Admin Could Drastically Change Research on Infectious Diseases
Via Investor Brand Network
Topics Government
Exposures Political
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Engage Investors and Partners at Key January Conferences
Via Investor Brand Network
Researchers Identify Protein That Makes Cancer Evade Cell Therapy
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Strategic Board Appointment
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Scinai Immunotherapeutics Ltd. - American Depositary Shares publicly traded?
Yes, Scinai Immunotherapeutics Ltd. - American Depositary Shares is publicly traded.
What exchange does Scinai Immunotherapeutics Ltd. - American Depositary Shares trade on?
Scinai Immunotherapeutics Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares is SCNI on the Nasdaq Stock Market
What is the current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 2.260
When was Scinai Immunotherapeutics Ltd. - American Depositary Shares last traded?
The last trade of Scinai Immunotherapeutics Ltd. - American Depositary Shares was at 06/18/25 03:33 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.